- Lobbying
- Lobbying by Pharmaceutical Printed Literature Association
Lobbying Relationship
Bills mentioned
H.R.3164: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Sanford D. Bishop Jr. (D-Ga.)
H.R.2500: National Defense Authorization Act for Fiscal Year 2020
Sponsor: Adam Smith (D-Wash.)
H.R.5198: Patients' Right to Know Their Medication Act of 2019
Sponsor: Jared Golden (D-Maine)
H.R.7614: Departments of Labor, Health and Human Services, and Education, and...
Sponsor: Rosa DeLauro (D-Conn.)
H.R.6519: Patients’ Right to Know Their Medication Act of 2022
Sponsor: Jared Golden (D-Maine)
H.R.1173: Patients’ Right to Know Their Medication Act of 2023
Sponsor: Buddy Carter (R-Ga.)
H.R.1503: Prescription Information Modernization Act of 2023
Sponsor: Diana Harshbarger (R-Tenn.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Erik Olson | Chief of Staff for Rep. Ron Kind |
Michael Spira | Chief of Staff for former Congresswoman Carolyn McCarthy (D-NY) and Deputy Chief of Staff for Congressman Ed Perlmutter (D-CO) |
Michelle Seger | Legislative Counsel for Congressman Alex Mooney (R-NY), Staffer of the Senate Judiciary Committee for Chuck Grassley (R-IA) Legislative Counsel for Congressman Alex Mooney (R-NY), Staffer of the Senate Judiciary Committee for Chuck Grassley (R-IA) |
Kelly Ferguson | Medicare Health Fellow - House Republican Policy Committee, Rep. Bill Cassidy (R-LA) |
John Richter | Legislative Assistant, Rep. Michelle Lujan Grisham (D-NM) |
Peter Goelz | n/a |
Bridget Anshus | n/a |
Malik Ross | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate